COMPANY
Hera Biotech
Timeline
- Trial start Phase 2: Proof of Concept Study to Eval MetriDx Lab-developed Test to Identify Endometriosis-specific Bio Markers source ↗
Clinical trials (lead sponsor) 1
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT05698212 | Proof of Concept Study to Eval MetriDx Lab-developed Test to Identify Endometriosis-specific Bio Markers | Phase 2 | Recruiting | Sep 14, 2022 | Mar 25, 2023 (estimated) |